Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PAREXEL International Corp (NASDAQ:PRXL)

65.41
Delayed Data
As of Dec 09
 +0.14 / +0.21%
Today’s Change
51.16
Today|||52-Week Range
71.13
-3.98%
Year-to-Date
3 Biotech Stocks to Buy on Sale
Nov 29 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close65.27
Today’s open65.54
Day’s range65.08 - 66.20
Volume1,025,287
Average volume (3 months)691,198
Market cap$3.5B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+7.92%
Earnings growth (this year)+9.32%
Earnings growth (next 5 years)+11.30%
Revenue growth (last year)+4.10%
P/E ratio21.0
Price/Sales1.40
Price/Book5.46

Competitors

 Today’s
change
Today’s
% change
CRLCharles River Labora...+0.63+0.86%
PRAHPRA Health Sciences ...+0.43+0.79%
ICLRICON PLC-0.06-0.08%
INCRINC Research Holding...+0.30+0.60%
Data as of 4:02pm ET, 12/09/2016

Financials

Next reporting dateFebruary 1, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$2.4B
Annual profit (last year)$154.9M
Net profit margin6.38%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Josef H. von Rickenbach
President &
Chief Operating Officer
Mark A. Goldberg
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs